News
ARE
119.18
+2.73%
3.17
Analyst Expectations For Alexandria Real Estate's Future
Alexandria Real Estate Equities Inc is an urban office real estate investment trust. The company has an average price target of $132.25. In the past three months, 4 analysts have released ratings for Alexandria Real Estate. The average 12-month price target has decreased by 2.94% from $136.25 to $126.00.
Benzinga · 1d ago
Alexandria Real Estate Price Target Cut to $126.00/Share From $133.00 by Evercore ISI Group
Dow Jones · 1d ago
Alexandria Real Estate Cut to In-Line From Outperform by Evercore ISI Group
Dow Jones · 1d ago
Evercore ISI Group Downgrades Alexandria Real Estate to In-Line, Lowers Price Target to $126
Benzinga · 1d ago
Alexandria Real Estate downgraded at Wedbush after 'noisy' Q2 results
Seeking Alpha · 2d ago
If I Had To Retire Today With 12 REITs
Seeking Alpha · 2d ago
Alexandria Real Estate Price Target Cut to $130.00/Share From $140.00 by Wedbush
Dow Jones · 2d ago
Alexandria Real Estate Cut to Neutral From Outperform by Wedbush
Dow Jones · 2d ago
Wedbush Downgrades Alexandria Real Estate to Neutral, Lowers Price Target to $130
Benzinga · 2d ago
Analysts’ Opinions Are Mixed on These Real Estate Stocks: CoStar Group (CSGP) and Alexandria Equities (ARE)
TipRanks · 2d ago
US Home Sales See Sharpest Monthly Decline In 1.5 Years As Record High Prices Keep Buyers On The Sideline
Existing home sales in the United States plunged 5.4% in June 2024 from the previous month. The median existing-home price for all housing types reached a record high for the second consecutive month. All four U.S. Regions saw both sales declines and price gains in June.
Benzinga · 3d ago
Alexandria (ARE) Q2 AFFO Beats Estimates, Revenues Miss
NASDAQ · 3d ago
Alexandria Real Estate Price Target Maintained With a $140.00/Share by JMP Securities
Dow Jones · 3d ago
JMP Securities Reiterates Market Outperform on Alexandria Real Estate, Maintains $140 Price Target
Benzinga · 3d ago
Analysts Offer Insights on Real Estate Companies: Alexandria Equities (ARE) and Equity Lifestyle (ELS)
TipRanks · 3d ago
Alexandria Real Estate Equities (ARE) Reports Q2 Earnings: What Key Metrics Have to Say
NASDAQ · 4d ago
Alexandria Real Estate Equities (ARE) Surpasses Q2 FFO Estimates
NASDAQ · 4d ago
Earnings Summary: Alexandria Real Estate posts mixed Q2, keeps FY adjusted FFO forecast unchanged
Seeking Alpha · 4d ago
Alexandria Real Estate Q2 AFFO slightly better than expected; maintains 2024 guide
Seeking Alpha · 4d ago
Alexandria Real Estate Equities Raises FY24 EPS Outlook From $2.98-$3.10 To $3.60-$3.72 Vs $3.38 Est.
Alexandria's projected 2024 earnings per share and funds from operations per share, as adjusted, range from $9.2024 to $10.47. The company expects to fund a significant portion of its capital requirements in the year ending December 31, 2024. The Company has completed several dispositions and is in negotiations to sell additional properties.
Benzinga · 4d ago
More
Webull provides a variety of real-time ARE stock news. You can receive the latest news about Alexandria Real Estate Eq Inc through multiple platforms. This information may help you make smarter investment decisions.
About ARE
Alexandria Real Estate Equities, Inc. is a life science real estate investment trust. The Company is an owner, operator and developer of collaborative life science, agricultural technology (agtech), and advanced technology mega campuses in AAA innovation cluster locations, including Greater Boston, the San Francisco Bay Area, New York City, San Diego, Seattle, Maryland, and Research Triangle. The Company, through its venture capital platform, provides strategic capital to life science, agrifoodtech, climate innovation, and technology companies. Its tenants include multinational pharmaceutical companies; public and private biotechnology companies; life science product, service and medical device companies; digital health, technology, and agtech companies; academic and medical research institutions; United States government research agencies; non-profit organizations, and venture capital firms. It has a Labspace asset base predominantly concentrated in markets with barriers to entry.